F-Star Alpha Limited

F-star Therapeutics is a private Cambridge-based biotech company focused on developing next-generation multispecific bispecific antibody therapeutics for cancer and other serious diseases. The company's proprietary tetravalent bispecific antibody platform is clinically validated and patent-protected, enabling novel combinations of immune cell engagement and tumor targeting that conventional antibodies cannot achieve. F-star partners with global pharmaceutical companies through licensing agreements and collaborations to advance immunotherapy and immuno-oncology programs to patients.